LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease by Jennings, Danna, Huntwork‐Rodriguez, Sarah, Vissers, Maurits F.J.M., Daryani, Vinay M., Diaz, Dolores, Goo, Marisa S., Chen, John J., Maciuca, Romeo, Fraser, Kyle, Mabrouk, Omar S., Wetering de Rooij, Jeroen, Heuberger, Jules A.A.C., Groeneveld, Geert Jan, Borin, Marie T., Cruz‐Herranz, Andrés, Graham, Danielle, Scearce‐Levie, Kimberly, De Vicente, Javier, Henry, Anastasia G., Chin, Peter, Ho, Carole, Troyer, Matthew D.

Get full text

Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti‐inflammatory 5‐lipoxygenase‐activating protein inhibitor by Bain, Gretchen, King, Christopher D., Schaab, Kevin, Rewolinski, Melissa, Norris, Virginia, Ambery, Claire, Bentley, Jane, Yamada, Masanori, Santini, Angelina M., Wetering de Rooij, Jeroen, Stock, Nicholas, Zunic, Jasmine, Hutchinson, John H., Evans, Jilly F.

Get full text

Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7 by BOONSTRA, Andre, LIU, Bi-Sheng, BAUMAN, Lisa A, RAHIMY, Mohamad, APPLEMAN, James R, FREDDO, James L, REESINK, Hendrik W, DE KNEGT, Robert J, JANSSEN, Harry La, GROOTHUISMINK, Zwier Ma, BERGMANN, Jilling F, DE BRUIJNE, Joep, HOTHO, Daphne M, HANSEN, Bettina E, VLIET, Andre A.van, DE WETERING DE ROOIJ, Jeroen Van, FLETCHER, Simon P

Get full text

Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design by HOTHO, Daphne M, DE BRUIJNE, Joep, SCHINKEL, Janke, MOLENKAMP, Richard, DE WETERING DE ROOIJ, Jeroen Van, VLIET, Andre Van, JANSSEN, Harry La, DE KNEGT, Robert J, REESINK, Hendrik W, O'FARRELL, A. Marie, BOYEA, Teresa, JIANKE LI, BRACKEN, Michele, XIN LI, CAMPBELL, David, GULER, Hans-Peter, WEEGINK, Christine J

Get full text

Safety and antiviral activity of JTK-652: a novel HCV infection inhibitor by de Bruijne, Joep, Bergmann, Jilling F, Weegink, Christine J, van Nieuwkerk, Carin M J, de Knegt, Robert J, Komoda, Yasumasa, van de Wetering de Rooij, Jeroen J, van Vliet, Andre, Jansen, Peter L M, Molenkamp, Richard, Schinkel, Janke, Reesink, Hendrik, Janssen, Harry L A

Get full text

Pharmacodynamics, pharmacokinetics and safety of GSK 2190915, a novel oral anti‐inflammatory 5‐lipoxygenase‐activating protein inhibitor by Bain, Gretchen, King, Christopher D., Schaab, Kevin, Rewolinski, Melissa, Norris, Virginia, Ambery, Claire, Bentley, Jane, Yamada, Masanori, Santini, Angelina M., van de Wetering de Rooij, Jeroen, Stock, Nicholas, Zunic, Jasmine, Hutchinson, John H., Evans, Jilly F.

Get full text